Testing effectiveness (Phase 2)UnknownNCT00002589What this trial is testingLymphocyte Therapy in Treating Patients With Kidney CancerWho this might be right forKidney Cancer National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT01688973What this trial is testingTivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by SurgeryWho this might be right forRecurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more National Cancer Institute (NCI) 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04523272What this trial is testingTQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal CancerWho this might be right forAdvanced Renal Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 528
Not applicableStudy completedNCT02526511What this trial is testingPerfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney TumorsWho this might be right forStage I Renal Cell CancerStage II Renal Cell CancerStage III Renal Cell Cancer+1 more Rutgers, The State University of New Jersey 75
Large-scale testing (Phase 3)Study completedNCT02240017What this trial is testingA Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.Who this might be right forAdvanced Urothelial CancerMetastatic Urothelial Cancer Institut Claudius Regaud 46
Early research (Phase 1)Study completedNCT00623064What this trial is testingLapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter European Organisation for Research and Treatment of Cancer - EORTC 18
Testing effectiveness (Phase 2)Study completedNCT00004157What this trial is testingInterleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsWho this might be right forBreast CancerGestational Trophoblastic TumorKidney Cancer+5 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022343What this trial is testingNeoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8 Emory University 22
Testing effectiveness (Phase 2)Study completedNCT00354250What this trial is testingIspinesib in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)UnknownNCT01118039What this trial is testingSunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Hospital del Mar 41
Large-scale testing (Phase 3)Study completedNCT00420888What this trial is testingABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Active Biotech AB 526
Not applicableActive Not RecruitingNCT02664883What this trial is testingMyeloid Derived Suppressor Cells Clinical Assay in Finding Kidney CancerWho this might be right forHealthy SubjectMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+3 more University of Southern California 37
Large-scale testing (Phase 3)Study completedNCT01223027What this trial is testingStudy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Novartis Pharmaceuticals 564
Large-scale testing (Phase 3)Study completedNCT00732914What this trial is testingSequential Study to Treat Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Sponsor GmbH 272
Testing effectiveness (Phase 2)Study completedNCT00792025What this trial is testingSunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Institut Curie 80
Very early researchActive Not RecruitingNCT02812420What this trial is testingDurvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before SurgeryWho this might be right forHydronephrosisInfiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma, Micropapillary Variant+16 more M.D. Anderson Cancer Center 54
Large-scale testing (Phase 3)Study completedNCT00087022What this trial is testingMonoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney CancerWho this might be right forKidney Cancer Heidelberg Pharma AG 864
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12